Destination Wealth Management
Position in IDXX — Idexx Laboratories Inc /De
CIK 1278573
WALNUT CREEK, CA
Position in IDXX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$482,745
+$34,919 QoQ
Shares Held
917
+15.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#782
of 1,286 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Destination Wealth Management holds $25,410,076 across 6 Diagnostics & Research names. IDXX ranks #3 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
43,630 | $21,874,336 | |
| 2 | DHR |
Danaher Corp /De/
|
9,982 | $1,901,371 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
This page
|
917 | $482,745 | |
| 4 | A |
Agilent Technologies, Inc.
|
3,052 | $405,397 | |
| 5 | DGX |
Quest Diagnostics Inc
|
1,773 | $375,787 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,323 | $370,440 |
All Filings in IDXX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $482,745 | 917 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $447,826 | 797 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $523,634 | 774 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $509,195 | 797 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $421,026 | 785 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $327,980 | 781 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $319,589 | 773 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||